What one share of SkyAI holds
Technology, Inc. (“Sharps” or the “Company”) is a medical device sales and distribution enterprise engaged in the marketing and distribution of syringe products and related drug-delivery systems. Prior to August 24, 2025, the Company was also focused on design and manufacture of a portfolio of conventional and safety syringes.
SkyAI’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$6.53 |
| Cash and investments | $0.28 |
| Book value | $3.66 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2025 | $0.01 | −$11.16 | — | — | — | $9.12 |
Common questions about SkyAI
How much does one share of SkyAI earn?
Over the last 12 months, SkyAI lost $6.53 for each share on $0.00 of sales.
Does SkyAI pay a dividend?
SkyAI didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is SkyAI’s book value per share?
SkyAI’s book value is $3.66 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of SkyAI have?
Each share of SkyAI has $0.28 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.